Press releases

New tool available to assist in the treatment of peripheral arterial disease.

Clinical presentations will provide new insights on Boston Scientific research in cardiovascular disease, including aortic valve disease and atrial fibrillation.

Extensive sales resources, distribution network and service capabilities are expected to enable Boston Scientific to reach substantially more accounts, customers and patients in Japan.

The next advance in durable polymer stent technology from Boston Scientific is now available in Europe and other select geographies.

Organizations team up to raise awareness and make a call to action for European governments to develop comprehensive chronic pain treatment programs.